ProActive Remedies, LLC Announces Launch of New Allergy ...(s in Americans. In 1996 allergic rhiniti...),Health

Date:3/27/2008

s in Americans. In 1996, allergic rhinitis was estimated to have an overall cost of $6 billion in the U.S. The AAAAI also notes that up to 90 percent of those with seasonal allergic rhinitis and up to 80 percent of those with perennial allergic rhinitis are able to successfully treat their condition with immunotherapy. Not all patients qualify for allergy shots, or are able to commit to the rigorous schedule of appointments. The ALLERTHERAPY line of liquid immunotherapy spray is simple to administer and available over the counter as an alternative treatment option. Those with serious allergies or other medical conditions should use ALLERTHERAPY under doctor supervision only. For more information about ALLERTHERAPY, please visit the website at http://www.allertherapy.com. Orders may be placed online or by calling 1 (877) GO-ALLER or 1 (877) 462-5537.

For additional information, contact:

Contact Person: Connie Williams

Company: ProActive Remedies, LLC

Phone: (800) 874-0989 ext. 300

Fax: (703) 637-9893

Email: information@proactiveremedies.com

Online: http://www.allertherapy.com

Phone Orders: (877) GO-ALLER / (877) 462-5537

ProActive Remedies, LLC is dedicated to developing products that empower consumers. The company conducts extensive research to define consumer needs and to develop and market cutting-edge products. The release of ALLERTHERAPY is the result of this process.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

'/>"/>

SOURCE ProActive Remedies, LLC Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine news :

1. Virginia School District Gets Proactive Against MRSA
2. Cancer care providers need to proactively address patients psychological and social needs
3. BJs Charitable Foundation Announces Q4 Donation of More Than $500,000 to Programs That Benefit Children and Families
4. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
5. ThalesNano Announces the Launch of X-Cube Flash(TM), its Next Generation High Temperature and Pressure Continuous Process Reactor
6. Laureate Announces Second Manufacturing Agreement with Cytheris
7. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
8. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
9. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
10. Hillenbrand Industries, Inc. Announces Pricing of Its Pending Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
11. EnergyNow! Announces New Grant Funding to Combat Childhood Obesity